Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Human B7-H3 (CD276) Fc Chimera Recombinant Protein

Click to view available options
Quantity:
1 mg
100 μg
Description
It is recommended that the protein be aliquoted for optimal storage. It is recommended that sterile water (500 μL) be added to the vial to prepare a stock solution of 0.25 mg/mL. Concentration is measured by UV.
CD276 is a member of the B7 family of co-stimulatory molecules also known as B7-H3. CD276 is a type I transmembrane protein that induces the proliferation of CD4+ and CD8+ T cells, enhances the generation of cytotoxic T cells and selectively stimulates the production of interferon gamma. Expression of CD276 can be induced on dendritic cells and monocytes by inflammatory cytokines, and is also widely expressed in peripheral tissues including the heart, kidney, testis and colon. In humans, CD276 exists as two isoforms which result from gene duplication and differential splicing. CD276 is reported to have therapeutic potential for the regulation of cell-mediated immune responses to cancer, particularly in conjunction with anti-angiogenic therapy.

Specifications
Specifications
Accession Number | Q5ZPR3 |
Concentration | 0.25 mg/mL |
For Use With (Application) | Control |
Format | Lyophilized |
Formulation | PBS with 0.01% Tween 80, 5% mannitol, 5% trehalose and no preservative; pH 7.4 |
Gene ID (Entrez) | 80381 |
Molecular Weight (g/mol) | 109.5 kDa |
Name | Human B7-H3 (CD276) Fc Chimera |
Purification Method | SDS-PAGE |
Quantity | 1 mg |
Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction